The functionality of IOP-lowering drainage devices may be greatly increased in the near future due to the work of Dr. Lee and his team, who have begun using magnetic technologies to keep these devices from being clogged and adjust flow resistance.
OIS is primarily focused on the development of new ophthalmic innovations but how much of a company’s success is attributable to the efficacy of their product vs their commercial/business strategy?
Through our partnership with OIS, Ethis & EyeCare Tomorrow are pleased to announce the OIS @ SECO Agenda!
http://eyecaretomorrow.com/blog/2019/2/19/ois-seco